AbbVie Inc · News · TradingHolo

AbbVie Inc · News · TradingHolo

ABBV news

Headlines tagged to this company

Global healthcare companies invest billions to boost US presence

Reuters · 14 d ago

AbbVie, Genmab's Epcoritamab Plus R-CHOP Improves PFS In DLBCL

dpa-AFX · 14 d ago

Genmab, AbbVie blood cancer drug combo cuts risk of progression or death in late-stage study

Reuters · 14 d ago

Abbvie - Q3 2026 GAAP And Adjusted Earnings Include $216 Million Bought Ipr&D And Milestones Expense - SEC Filing

Reuters · 14 d ago

AbbVie flags $216M IPR&D and milestones expense for Q3

Seeking Alpha · 14 d ago

Genmab, AbbVie data boosts Epkinly as first-line B-cell lymphoma treatment

Seeking Alpha · 14 d ago

AbbVie blood cancer drug combo cuts risk of progression or death in late-stage study

Reuters · 14 d ago

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

BusinessWire · 15 d ago

Genmab and AbbVie Announce Epcoritamab in Combination with R-CHOP Demonstrates Statistically Significant Improvement in Progression-Free Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma

GlobeNewswire · 15 d ago

Regenxbio a new Outperform at Mizuho on potential of two pipeline drugs

Seeking Alpha · 15 d ago

AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot

Seeking Alpha · 17 d ago

AbbVie joins US government pilot to test drug discount rebates

Reuters · 17 d ago

Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma

Seeking Alpha · 17 d ago

Medicare drug pricing model to affect only four firms after Trump’s MFN policy

Seeking Alpha · 18 d ago

Major drugmakers turn to China for licensing deals

Reuters · 18 d ago

Abbvie Says Phase 3 Studies Show Continued Repigmentation With Rinvoq Through Week 76

Reuters · 19 d ago

AbbVie long-term data buoys Rinvoq for vitiligo

Seeking Alpha · 19 d ago

AbbVie to Host Third-Quarter 2026 Earnings Conference Call

PR Newswire · 19 d ago

Key facts: AbbVie (ABBV) Upadacitinib Phase 3; ABBV-295 Phase 2

TradingView · 19 d ago

AbbVie To Present New Dermatology Data At 2026 EADV Congress

dpa-AFX · 20 d ago

← Previous More news →